Physician profile
Travis Hughes
NPI 1780070110
$29,092.62
in general payments reported to CMS, 2019-2025
10 companies · $8,316 in 2025
The $8,316 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $3,729 · 2022: $2,399 · 2023: $1,732 · 2024: $2,795 · 2025: $8,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,710 · Food and Beverage: $5,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,709.52 |
| Food and Beverage | $5,133.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,355.21 | 2020-2021 | |
| Stryker Corporation | $6,222.69 | 2021-2025 | Pro, Gamma, Pangea |
| Medical Device Business Services, INC. | $5,402.09 | 2024-2025 | Va-Lcp, Tfn-Advance |
| Smith+Nephew, INC. | $3,240.18 | 2020-2025 | Trigen Intertan, Evos, Aetos Shoulder System |
| Medinc of Texas | $397.28 | 2023-2025 | |
| Depuy Synthes Sales INC. | $159.16 | 2024-2025 | Na, Tfn-Advance, Va-Lcp |
| Medtronic, INC. | $150.17 | 2022 | |
| Bioventus LLC | $112.39 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Axogen | $35.28 | 2025 | |
| Zimmer Biomet Holdings, INC. | $18.17 | 2023 | Xtrafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.